The QualityStocks Daily Stock List
- Innovation Pharmaceuticals, Inc. (IPIX)
- Nemaura Medical, Inc. (NMRD)
- Blox, Inc. (BLXX)
- Liberated Syndication, Inc. (LSYN)
- GripeVine, Inc. (GRPV)
- NaturalShrimp, Inc. (SHMP)
- Ocean Thermal Energy Corporation (CPWR)
- Mymetics Corp. (MYMX)
- OP Bancorp (OPBK)
- MedMen Enterprises, Inc. (MMNFF)
- Golden Matrix Group, Inc. (GMGI)
- FISION Corp. (FSSN)
- Asaleo Care Limited (ASLEF)
- Integrated Cannabis Company, Inc. (ICNAF)
Innovation Pharmaceuticals, Inc. (IPIX)
Streetwise Reports, Real Investment Advice, Simply Wall St, Stockhouse, The OTC Reporter, Tip Ranks, Insider Financial, Stockopedia, Emerging Growth, Stockdigest Report, MarketWatch, Wallet Investor, Investors Hangout, Barchart, and InvestorsHub reported on Innovation Pharmaceuticals, Inc. (IPIX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Innovation Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It is developing innovative therapies in many diseases and its belief is that it has a first-rate portfolio of first-in-class lead drug candidates. The Company is now advancing them toward market approval, while actively seeking strategic partnerships. Innovation Pharmaceuticals is based in Beverly, Massachusetts.
The Company has established research collaborations with world-renowned research institutions in the United States and Europe. These include MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.
Innovation Pharmaceuticals’ anti-cancer drug is Kevetrin. It successfully concluded a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. The Company has started a Phase 2 study in Ovarian Cancer.
Innovation has its Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention of OM in patients with head and neck cancer. Brilacidin - a defensin mimetic compound - has shown in an animal model to lessen the occurrence of severe ulcerative Oral Mucositis (OM) by more than 94 percent in comparison to placebo.
Brilacidin completed a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infection, or ABSSSI. Top-line data have shown a single dose of Brilacidin to deliver comparable clinical outcomes to the Food and Drug Administration (FDA)-approved seven-day dosing regimen of daptomycin.
Innovation’s Psoriasis drug candidate is Prurisol. It completed a Phase 2 trial and the Company has launched a Phase 2b study. Prurisol is a small molecule. It acts by way of immune modulation and PRINS reduction.
Earlier this month, Innovation Pharmaceuticals provided a corporate update highlighting business development and clinical pipeline priorities across its first-in-class drug candidates, Brilacidin, Prurisol and Kevetrin.
Mr. Leo Ehrlich, Innovation Pharmaceuticals’ Chief Executive Officer, said, “A successful End-of-Phase 2 FDA meeting for our Brilacidin-Oral Mucositis asset, or positive results from our Phase 2b Prurisol trial in psoriasis—either outcome we believe would open up enormous possibilities for our shareholders. We look forward to updating shareholders on these, and other company developments, as we continue to lay a strong scientific foundation upon which future successes can be built.”
Innovation Pharmaceuticals, Inc. (IPIX), closed Wednesday's trading session at $0.133, up 0.76%, on 875,275 volume with 103 trades. The average volume for the last 3 months is 657,204 and the stock's 52-week low/high is $0.1025/$1.17.
Nemaura Medical, Inc. (NMRD)
Business Wire, Market Exclusive, Barchart, OTC Markets, Stockhouse, Simply Wall St, InvestorsHub, and 4-Traders reported earlier on Nemaura Medical, Inc. (NMRD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Nemaura Medical, Inc. is a medical technology company developing the wireless sugarBEAT® disposable adhesive skin-patch as a non-invasive, needle-free, pain-free, and affordable continuous glucose monitoring (CGM) system for adjunctive use by diabetics. The Company’s patient-friendly technology has the potential to transform health monitoring through providing real-time, tailored feedback on glucose, lactate, as well as other important body performance metrics. Nemaura Medical is based in Loughborough, England.
The Company’s patented BEAT™ technology (passing a mild, non-perceptible electric current across the skin) draws a small number of selected molecules, such as glucose, into a patch placed on the skin. These molecules are drawn out of the interstitial fluid. The patch - by way of a sensor - measures the amount of that molecule present, converting it into a meaningful concentration value for clinical diagnosis or preliminary guidance for self-treatment.
The BEAT™ technology will enable remote continuous monitoring of chronic diseases and health conditions. It is to replace traditional invasive methods of diagnosis and healthcare observation procedures.
The sugarBEAT® App can be pre-downloaded on a user’s smart device. There is an optional sugarBEAT® handheld reader (applicable where a user chooses not to use their own smart device). sugarBEAT® provides accurate glucose measurement. It consists of a reusable transmitter containing a daily-disposable adhesive skin-patch.
Nemaura Medical announced in July 2018 that it began the first of a number of planned studies in support of a submission to the U.S Food & Drug Administration (FDA) for approval of its sugarBEAT® product. It further announced positive interim results from the home-use portion of this initial study. The anticipation is that the initial U.S. study will enroll 75 patients wearing the device over a 7-day period, including 3 days in a clinical setting (525 total patient days; 225 total in-clinic days). Initial U.S. study completion and FDA submission is anticipated in Q1 2019.
Last week, Nemaura Medical announced that it signed an exclusive license and distribution agreement with Al-Danah Medical Co. This is for the commercial launch of sugarBEAT® in Qatar in readiness for a 2019 launch. Al-Danah Medical Company is part of the Almana Group. Al-Danah is a foremost medical product distributor in Qatar, representing many international brands.
Nemaura Medical, Inc. (NMRD), closed Wednesday's trading session at $1.77, up 2.91%, on 10,713 volume with 27 trades. The average volume for the last 3 months is 155,649 and the stock's 52-week low/high is $1.57/$6.80.
Blox, Inc. (BLXX)
Stockwatch, OTC Markets Group, Insider Wisdom, SmallCapVoice, Dividend Investor, PennyStocks24, Capital Cube, Investors Hangout, Marketwired, Savvy Trader Resource, and Real Investment Advice reported previously on Blox, Inc. (BLXX), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Blox, Inc.’s vision is to pioneer the development of mining projects through applying green innovation to traditional mining methods and combining renewable energy and technology into the process. The Company’s plan is to become a global leader in the production of “green minerals”. Blox Minerals is a wholly-owned subsidiary of Blox, Inc. Blox is headquartered in Vancouver, British Columbia and the Company lists on the OTC Markets’ OTCQB.
Blox defines “green minerals” as minerals produced using technologies, best practices, and mine processes implemented to lessen the environmental impacts associated with the extraction and processing of metals and minerals. The Company’s plan is to use renewable energy and technology in the production of green minerals with the aim of turning expensive costs into profits through utilizing renewable energy plants to power its varied projects.
A vital aspect of Blox’s mandate is to implement clean energy into the mining process. This is to effectively “green” the mining process and minimize its environmental impact through lower hydrocarbon emissions. Blox’s plan is to build a portfolio of gold and other minerals and produce them in a socially and environmentally friendly way. Its key concession holdings are in Ghana and Guinea, West Africa. Its projects include Pramkese, Osenase, Asamankese, and Mansounia.
The Mansounia Exploration Licence is centered on Latitude 10º 23’ N and Longitude 9º 47’ W in the Kouroussa Prefecture, Kankan Region, in Guinea, West Africa. It encompasses a surface area of 145 square kms. At Mansounia, significantly fresh rock mineralization has been intersected and as of July 2016, remains unexplored. Mansounia is a priority development asset for the Company.
Blox has entered into a Strategic Alliance Agreement with Ashanti Sankofa, Inc. With this Strategic Alliance Agreement, both parties agreed to grant to the other party a right of first refusal to enter into a joint venture (JV) on any of their respective properties and/or projects and that any future acquisition of natural resource properties, which may be acquired by either party that contains, but is not limited to, gold, precious metals, technology metals or diamonds (Natural Resource Properties), the acquiring party will grant to the other party a right of first refusal to participate in a JV on such Natural Resource Property that shall be at the sole discretion of the acquiring party.
In October, Blox announced that results received from its auger drilling campaign at Mansounia identified five additional targets. This includes doubling the strike of the Mansounia South Prospect to more than 5 km long. Mansounia contains a current JORC Compliant resource of 1.29-million ounces at a pre-feasibility stage. The project is in the highly prospective Siguiri Basin region of Eastern Guinea.
Mr. Trevor Pickett, Chief Executive Officer of Blox, said last month, "I am excited about the new drill targets identified and the extensions of the drill ready targets unveiled by the auger drilling. Anomalies were revealed in every drill line commenced, which is a very positive sign. These results have given us confidence to move forward with our plans to raise capital to complete the current auger program and then plan high quality resource extensional drilling. We are also well advanced towards the submission of our Mining License application for the Mansounia Gold Project."
Blox, Inc. (BLXX), closed Wednesday's trading session at $0.14, even for the day. The average volume for the last 3 months is 892 and the stock's 52-week low/high is $0.071/$0.30.
Liberated Syndication, Inc. (LSYN)
Promotion Stock Secrets reported on Liberated Syndication, Inc. (LSYN), and we also report on the Company, here at the QualityStocks Daily Newsletter.
Liberated Syndication, Inc. engages in the podcast hosting services business in the United States. The Company previously went by the name Webmayhem, Inc. It changed its name to Liberated Syndication, Inc. in August of 2016. The Company has its corporate office in Pittsburgh, Pennsylvania. Liberated Syndication’s shares trade on the OTC Markets’ OTCQB.
Regarding the Company’s OnPublish – Multiple Destination Publishing, Liberated Syndication’s services provide independent podcasters tools to create a first-rate podcast and get that podcast into as many platforms as possible. The Company is the largest leading podcast network. It provides podcast hosting services for producers of podcasting content; independent podcasters’ tools to publish content; and mobile apps for podcasts.
Liberated Syndication also offers advertisement insertion on certain of the producers’ content. Pertaining to Podcast Hosting Services, hosting is optimized for audio and video podcast distribution. The network is fast and reliable, and unmetered bandwidth and flexible storage space increases over time.
The Liberated Syndication publishing platform integrates content delivery to social media and blog platforms through OnPublish, the Company’s Facebook App and HTML5 player. OnPublish incorporates publishing to Facebook, Twitter, WordPress and Blogger right from Liberated Syndication (Libsyn).
Concerning MyLibsyn – Premium Content, it is a complete subscription management service. The MyLibsyn offering includes a custom premium page and mobile apps available across four markets. One’s subscribers sign up and create one username and password. They can access their subscription across all available apps and one’s branded premium page.
Liberated Syndication also has its LibsynPRO – Enterprise Solutions. This is for professional media producers and corporate customers. LibsynPRO features podcast network tools. It is a turn-key podcast network solution and it allows for as many different shows and episodes as required. In addition, effective reports convey sophisticated data on network, show, episode, device, and geographic performance.
Concerning Mobile Apps for Podcast, the Libsyn custom smartphone app for podcasters involves audiences beyond one’s regular audio or video episodes. Four different kinds of content are accepted by the app (audio, video, PDF and text). All in one place, a user can offer their audience extras, blog posts, transcripts, and more.
Earlier this month, Liberated Syndication announced that it closed its acquisition of Internet hosting company Pair Networks, Inc. on December 27, 2017. The Company paid $13.5 million in cash and issued 1,579,613 shares of restricted common stock valued at $2.5 million to acquire 100 percent of Pair Networks.
The combined businesses represented roughly $23 million in annual revenue and about $7 million in EBITDA (Earnings Before, Interest, Taxes, Depreciation, and Amortization) for 2017. As of December 31, 2017, the combined companies had roughly 82,000 monthly subscribers for hosting services. Management’s plan is to host a shareholder conference call during Q1 2018 to outline its plans for the combined companies in more detail.
Liberated Syndication, Inc. (LSYN), closed Wednesday's trading session at $1.50, up 0.17%, on 2,772 volume with 6 trades. The average volume for the last 3 months is 8,289 and the stock's 52-week low/high is $1.08/$1.89.
GripeVine, Inc. (GRPV)
MarketWatch, InvestorsHangout, InvestorsHub, Morningstar, and Stockhouse reported on GripeVine, Inc. (GRPV), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
GripeVine, Inc. is a company focusing on leading the revolution of social customer service. The Company is a proprietary complaint-resolution platform for the facilitation and management of social customer service through centralized communication, rating, and review tools. It has a highly scalable and sustainable growth model. GripeVine is based in Oakville, Ontario.
The Company’s mission is to establish itself as a worldwide leader in social consumer resolution and relationship management. It works to accomplish this through providing businesses strong tools to manage their social presence while providing consumers with tangible resolution results and a social engine.
GripeVine has a platform where, as the Company states, all sides can be heard. It has a user-friendly social CRM (Customer Relationship Management) platform for users to engage on.
The emphasis is on turning negative experiences into positive outcomes. Consumers with legitimate customer service complaints can post it (plant a gripe) and connect with companies who subsequently can interact with their customers on a level playing field to find a harmonious resolution.
GripeVine provides a thriving social engine for consumers and premier back end tools for businesses. GripeVine develops, owns, and operates social customer relations applications on desktop and mobile computing platforms.
The Company has unique patents. These patents drive a flourishing community and provide businesses first-rate control over their social public image.
The GripeVine Proprietary Process helps consumers achieve resolutions while enabling businesses to improve consumer loyalty. The Company’s platform includes the handling of ratings, reviews, and complaint resolution statuses. This is while offering data collection features including scoring, polling, comments, voting, and credibility points – all with the goal of creating a home for connections, resolution, business improvement, and loyalty enhancement.
High profiles companies and localized SME’s (small and medium-sized enterprises) use GripeVine. The Company expedites the resolution process between consumers and businesses. In essence, GripeVine creates a fair space for business and consumers to interact.
GripeVine, Inc. (GRPV), closed Wednesday's trading session at $0.26, up 4.00%, on 7,000 volume with 3 trades. The average volume for the last 3 months is 23,850 and the stock's 52-week low/high is $0.10/$0.30.
NaturalShrimp, Inc. (SHMP)
SmallCapVoice, Pennystockmania, ThePennyPicks, PennyPickGains, and WallstreetSurfers reported earlier on NaturalShrimp, Inc. (SHMP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, NaturalShrimp, Inc. is an international leader in aquaculture technology. The Company has developed and tested the first commercially-viable system for growing shrimp indoors. The system employs a proprietary technology to reliably produce healthy, naturally-grown shrimp weekly without the use of antibiotics or toxic chemicals. NaturalShrimp is based in Dallas, Texas.
NaturalShrimp’s production facility is outside of San Antonio, Texas. The Company’s European partner has built a production facility in Medina del Campo, Spain. Expansion plans include domestic and worldwide production facilities and distribution channels.
NaturalShrimp, Inc. owns 100 percent of NaturalShrimp Corporation, formed to operate in the United States and Canada, and 100 percent of NaturalShrimp Global, Inc., established to create International Joint Venture (JV) Partnerships.
NaturalShrimp has developed a technology to produce fresh, gourmet-grade shrimp dependably and economically in an indoor, re-circulating, saltwater facility. Its eco-friendly, bio-secure design does not depend on ocean water. It recreates the natural ocean environment allowing for high-density production, which can be replicated anywhere globally.
The NaturalShrimp Automated Monitoring and Control system utilizes individual tank monitors to automatically control the feeding, the oxygenation, and also the temperature of each of the facility tanks independently. In addition, a facility computer, running custom software, communicates with each of the controllers and performs additional data acquisition functions that can report back to a supervisory computer from anywhere in the world.
The computer automated water controls optimize the growing conditions for the shrimp as they mature to harvest size. This provides a disease-resistant production environment.
NaturalShrimp, along with its technology partner F&T Water Solutions, LLC, has teamed with Filtertech, Inc. on manufacturing the production equipment package to initially be installed at NaturalShrimp’s La Coste facility. The proprietary equipment package is the basis of the Company’s patented technology. The equipment covers NaturalShrimp’s base process of growing healthful, naturally grown shrimp without the use of chemicals and/or antibiotics.
In essence, NaturalShrimp’s production facilities will be the aquaculture industry’s first truly eco-friendly, sustainable way of cultivating shrimp in high density environments. The Company’s closed system production methods will produce fresh, gourmet grade shrimp without the use of antibiotics, pollutants, and other chemicals or without further depleting the globe’s oceans from overfishing.
Mr. Gerald Easterling, Mr. Bill G. Williams, and Mr. Tom Untermeyer founded NaturalShrimp in 2001. Mr. Williams serves as Chairman and Chief Executive Officer. Mr. Easterling serves as President. Mr. Untermeyer serves as Chief Technology Officer.
NaturalShrimp, Inc. (SHMP), closed Wednesday's trading session at $0.0287, up 4.36%, on 29,601,442 volume with 1,234 trades. The average volume for the last 3 months is 1,143,958 and the stock's 52-week low/high is $0.0049/$1.00.
Ocean Thermal Energy Corporation (CPWR)
OTC Markets, InvestorsHub, MarketWatch, YCharts, 4-Trders, Barchart, Investopedia, Marketbeat.com, Tidal Energy Today, Insider Monkey, Stockhouse, and Simply Wall St reported on Ocean Thermal Energy Corporation (CPWR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Ocean Thermal Energy Corporation constructs and operates clean hydrothermal energy plants around the world. The Company is a project developer for Ocean Thermal Energy Conversion (OTEC) plants that create renewable energy. It designs and develops deep-water hydrothermal clean-energy systems that produce fossil-fuel free electricity through OTEC and environmentally friendly cooling through Seawater Air Conditioning (SWAC).
Ocean Thermal Energy is headquartered in Lancaster, Pennsylvania. The Company has additional offices in the Bahamas, the Cayman Islands, and the U.S. Virgin Islands. Established in 1998, Ocean Thermal Energy lists on the OTC Markets’ OTCQB.
OTEC takes advantage of the temperature difference in the ocean between cold deep water and warm surface water in the tropics and subtropics to produce unlimited energy without the use of fossil fuels. In a closed cycle OTEC system, water flows through a large pipe and heat exchanger that heats a liquid with a low boiling point, such as ammonia.
As the boiling ammonia produces steam, it turns a turbine generator to generate electricity. A second pipe extracts cool deep water from the ocean that condenses the steam back to liquid form. As the ammonia is recycled, the process repeats, creating unlimited clean energy, 24 hours a day, 365 days a yea (The Rankine Cycle). OTEC uses the solar energy from the ocean. No fossil fuels are used.
Seawater Air Conditioning (SWAC) technology generates air conditioning without the use of chemical agents. Acting alone, SWAC can lessen electricity usage by up to 90 percent versus traditional air conditioning systems. When developed in association with OTEC plants, SWAC operates totally without the use of fossil fuels.
Last month, Ocean Thermal Energy announced that it has made major progress on the development of its first OTEC EcoVillage. The Company has progressed toward the development of a SWAC system for the U.S. Military.
Regarding the OTEC EcoVillage, the U.S. Virgin Islands’ Public Service Commission granted Ocean Thermal Energy regulatory approval for an OTEC plant. The Company has identified the specific plots of land for the site. The initial draft of the Master Plan for the whole development has been completed.
The OTEC EcoVillage project comprises, in part, of an OTEC plant that will provide all power and water to approximately 400 residences. Additionally, it comprises a hotel, and shopping center, and models of sustainable agriculture, food production, and other economic developments. OTEC EcoVillage will be the first development in the world offering a net-zero carbon footprint.
Ocean Thermal Energy Corporation (CPWR), closed Wednesday's trading session at $0.05, up 0.60%, on 240,290 volume with 4 trades. The average volume for the last 3 months is 101,139 and the stock's 52-week low/high is $0.037/$0.69.
Mymetics Corp. (MYMX)
TopPennyStockMovers, Market Intel Reports, and The Dean reported previously on Mymetics Corp. (MYMX), and we report on the Company today, here at the QualityStocks Daily Newsletter.
Mymetics Corp. is a biotechnology company listed on the OTC Markets Group’s OTCQB. The Company is developing next-generation preventative vaccines for infectious diseases. Its vision is to become the market leader in the development of new generation mucosal and virosomes based vaccines. Mymetics has its corporate office in Epalinges, Switzerland.
Mymetics has a Research Lab in the Netherlands. The Company’s core technology and expertise are in the use of virosomes, lipid-based carriers containing functional fusion viral proteins and natural membrane proteins, in combination with rationally designed antigens. Currently, Mymetics has a group of vaccines in its pipeline: HIV-1/AIDS, intra-nasal Influenza, Malaria, Chikungunya, Herpes Simplex Virus, and the RSV vaccine.
The design of the Company’s vaccines is to induce protection against early transmission and infection, focusing on the mucosal immune response as a first-line defense, which for some pathogens may be critical for the development of an effective prophylactic vaccine. The HIV, malaria, and intra-nasal influenza vaccines have successfully completed Phase 1 clinical trials. The others are in the pre-clinical phase.
Mymetics is concentrating on developing pioneering preventative vaccines utilizing two key scientific approaches. One is Virosomes as an effective adjuvant and a vaccine delivery method. The other is unique antigen design through generating mucosal antibodies.
Through focusing on these two scientific approaches, Mymetics’ strategy is addressing two important needs in developing effective vaccines. One is the ability to build a first line of defense against viruses entering the blood stream through centering on the mucosal layer. The other is the development of a new vaccine delivery platform that doesn’t use live attenuated or killed pathogens, while increasing the immunogenicity and stability of the vaccine.
Mymetics’ subsidiary, Mymetics B.V., has agreed on a research project with Sanofi Pasteur, the vaccine division of Sanofi (SNY). The project will investigate the immunogenicity of influenza vaccines based on Mymetics' proprietary virosome technology platform in pre-clinical settings.
Mymetics has recently presented new preclinical data. The new data demonstrates that nasal powder, oral capsules, and sublingual tablets developed by MACIVIVA partners, containing Mymetics HIV-1 virosome based vaccine candidate, could induce specific antibody immune response in rodent and mini-pig animal models.
The results are generated under the MACIVIVA project (an EU Horizon 2020 project) that stands for "Manufacturing process for Cold-chain Independent Virosome-based Vaccines." The project began in May of 2015. It has a duration total of 3.5 years.
This project brings together top contract manufacturers and the relevant expertise for spray drying, freeze drying, and analytical techniques from the pharmaceutical industry. This is to develop a scalable manufacturing process to attain thermostable and cold-chain independent virosome based vaccines.
Mymetics Corp. (MYMX), closed Wednesday's trading session at $0.065, up 3.59%, on 170,542 volume with 13 trades. The average volume for the last 3 months is 109,606 and the stock's 52-week low/high is $0.0155/$0.077.
OP Bancorp (OPBK)
The Street, Businesswire, TradingView, MarketWatch, and YCharts reported on OP Bancorp (OPBK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
A California corporation, OP Bancorp is the holding company for Open Bank. Open Bank engages in the general commercial banking business in Los Angeles and Orange Counties, California. The Bank concentrates on serving the banking needs of small- and medium-sized businesses, professionals, and residents with a specific focus on Korean and other ethnic minority communities.
The Company began its operations on June 10, 2005 as First Standard Bank. It changed its corporate name to Open Bank in October of 2010. OP Bancorp lists on the OTCQB and the Company is headquartered in Los Angeles.
At present, the Bank operates with seven full branch offices in Downtown Los Angeles, the Los Angeles Fashion District, Los Angeles Koreatown, Gardena and Buena Park. In addition, it has three loan production offices in Seattle, Washington; Dallas, Texas; as well as Duluth, Georgia.
Open Bank generates certificates of deposit, instalment accounts, money market accounts, retirement accounts, savings accounts, and various personal and business checking accounts. Additionally, it provides commercial lending products, such as business lines of credit, business term loans, and commercial real estate term loans; trade financing products and services consisting of issuance of letters of credit, import and export financing, revolving lines of credit, clean and documentary collections, and others.
Moreover, Open Bank offers small business administration lending products and home mortgage financial solutions. It also offers online banking, mobile banking, bill pay, and e-statement services. Open Bank’s vision and mission is to be known as a faith-based community bank centered on relationship banking.
This past July, OP Bancorp reported that Net Income for Q2 of 2017 was $2.46 million, or $0.18 per diluted common share. This is in comparison to Net Income of $2.15 million, or $0.15 per diluted share, for Q1 of 2017, and Net Income of $1.80 million, or $0.13 per diluted share, for Q2 of 2016.
Pre-Tax Pre-Provision Income was $4.3 million for Q2 2017, versus $4.1 million for Q1 2017, and $3.5 million for Q2 2016.
OP Bancorp (OPBK), closed Wednesday's trading session at $9.94, up 2.58%, on 34,100 volume with 179 trades. The average volume for the last 3 months is 31,367 and the stock's 52-week low/high is $8.89/$14.10.
MedMen Enterprises, Inc. (MMNFF)
OTC Markets, Penny Stock Hub, GuruFocus, OTC Stock Watch, Stockhouse, 4-Traders, Morningstar, Insider Financial, The Street, Wallmine, TradingView, Barchart, Stockwatch, OTC Stock Picks, New Cannabis Ventures, MarketWatch, Daily Marijuana Observer, Investors Hangout, and Investing News reported on MedMen Enterprises, Inc. (MMNFF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
MedMen Enterprises, Inc. brings expertise and capital to the cannabis industry. The Company is one of the nation’s largest financial supporters of progressive marijuana laws. MedMen Enterprises owns and operates 18 facilities covering the entire vertical from cultivation to manufacturing to retail in three key states - California, Nevada and New York. OTCQX-listed, MedMen Enterprises has its corporate headquarters in Los Angeles, California.
MedMen Enterprises manages class leading retail stores that sell marijuana and marijuana products. MedMen operates a number of dispensaries in the most strategic markets in the nation. It has a fast-growing footprint. This includes expansion plans in other important States as well as Canada.
MedMen has added ground cannabis flower to its product offerings in the State of New York. At present, Company stores in New York offer vaporizer pens, tinctures and gel caps in five different formulations. The addition of ground flower will give its New York medical marijuana patients more product choices in the State’s fast developing market.
MedMen Enterprises has a total of three stores planned for Las Vegas, Nevada. The Company earlier announced its expansion into a fourth key market, Florida, via a proposed acquisition of dispensary and cultivation assets from Treadwell Simpson Partnership and affiliates. MedMen Enterprises has secured prime retail locations with long term leases in Ft. Lauderdale, Miami Beach, West Palm Beach, St. Petersburg and Key West. The Company continues to expand its presence in premier retail districts with high visibility and heavy foot traffic.
MedMen has also acquired a dispensary and cultivation license and related assets from Florida based Treadwell Simpson Partnership and affiliates (Treadwell Nursery). This License permits MedMen to open 30 (and up to 35 if certain conditions are met) medical marijuana dispensaries in Florida and to conduct cultivation, delivery and manufacturing operations in the State. As part of the transaction, MedMen Enterprises acquired Treadwell Nursery’s cultivation facility located on five acres near Orlando.
Moreover, Captor Capital Corp. has signed a definitive agreement to sell the retail operations and license for a dispensary location in Santa Ana, California, via an all-stock transaction with MedMen Enterprises valued at roughly US$16 million. The store is now MedMen branded and managed. Upon closing, MedMen will issue about 3,740,228 Class B Subordinate Voting shares to Captor Capital. At current market price, the Agreement transaction is valued at US$16,229,567. The final purchase price is subject to adjustment for accrued liabilities at the time of closing.
MedMen Enterprises, Inc. (MMNFF), closed Wednesday's trading session at $3.3643, down 0.44%, on 1,122,853 volume with 1,941 trades. The average volume for the last 3 months is 1,977,703 and the stock's 52-week low/high is $2.609/$7.57.
Golden Matrix Group, Inc. (GMGI)
Tip Ranks, Stockflare, ClayTrader, Infront Analytics, InvestorsHub, Stockhouse, Penny Stock Tweets, Wallet Investor, Morningstar, MarketWatch, Investor Place, Penny Stock Hub, Barchart, GuruFocus, Real Investment Advice, Dividend Investor, Central Charts, Simply Wall St, YCharts, 4-Traders, last10k, and Capital Cube reported previously on Golden Matrix Group, Inc. (GMGI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Golden Matrix Group, Inc. is an established gaming technology company headquartered in Las Vegas, Nevada. It develops and owns online gaming Intellectual Property (IP). In addition, Golden Matrix builds configurable and scalable white-label social gaming platforms for its worldwide customers, located primarily in the Asia Pacific region.
Fundamentally, Golden Matrix Group pioneers highly modular, configurable and scalable social gaming platforms for its global customers. The Company does so in an effort to promote user acquisition, engagement, retention, and monetization. In strict compliance with current United States law, Golden Matrix’s sophisticated software automatically declines any gaming or redemption requests from within the United States. Its gaming IP includes tools for marketing, acquisition, retention and monetization of users. Its platform can be accessed through desktop and mobile applications.
Golden Matrix earlier entered into a definitive distribution agreement with Red Label Technology to expand the number of gaming operators being serviced by Golden Matrix in the Asia Pacific region. Red Label Technology is an Asian-based company. It is owned and operated by a team of experienced social gaming entrepreneurs with extensive distribution channels throughout Asia.
Red Label will be introducing its gaming operator clients/contacts to Golden Matrix’s New Generation GM-X System. This System is a state-of-the-art gaming platform. It incorporates an artificial intelligence (AI) component and a module that supports seamless integration with Sportsbooks and e-Sports.
Golden Matrix Group announced in August of this year that it launched and went live with its first four proprietary slot games. They are basic traditional Chinese Slot Games. Each game depicts one of the four seasons. They represent the first units of an exclusive Golden Matrix portfolio of games to be called GM Slots.
In September 2018, Golden Matrix announced it expanded its game content with the addition of a Gaming Master Portfolio (GMP) of 32 innovative games on popular themes, including Chinese legends. GMP is already featured on the Company’s state-of-the-art GM-X platform. This makes it available to all gaming operator clients and, subsequently, to greater than one million active players within their networks.
Yesterday, Golden Matrix announced that for Q1 ended October 31, 2018, it recorded Net Income of $331,999. This is in comparison to a Net Loss of $458,043 in Q1 ended October 31, 2017. First quarter 2019 Revenues of $638,695 represent a 25 percent increase in revenues of $510,656 in Q4 2018 and a 2,029 percent increase in Revenues of $30,000 in the comparable year-ago period.
Golden Matrix Group, Inc. (GMGI), closed Wednesday's trading session at $0.0011, down 15.06%, on 9,394,661 volume with 29 trades. The average volume for the last 3 months is 8,610,575 and the stock's 52-week low/high is $0.00019/$0.0028.
FISION Corp. (FSSN)
MarketWatch, TradingView, and Bloomberg reported on FISION Corp. (FSSN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
FISION Corp. is a cloud-based digital asset management and marketing automation company headquartered in Minneapolis, Minnesota. The Company serves enterprise clients in the health care, hospitality, financial/insurance, software, and technology industries. FISION has more than 65,000 users in 21 countries. Established in 2011, FISION lists on the OTC Markets Group’s OTCQB.
FISION is an effective sales enablement and marketing asset management tool. It maximizes the brand potential of every sales interaction. The Company’s advanced, proprietary technology specializes in managing customers’ brand and marketing content. This enables marketing and sales people to quickly and easily create compelling, personalized, on-brand communications, which increases revenue and profits.
FISION’s solutions include simplified brand distribution, sales enablement, distributed & localized marketing, digital asset management, channel support, and measurement & analytics. The Company equips marketing and sales teams with a comprehensive set of enablement capabilities built to solve distributed marketing challenges. Concerning digital asset management, FISION’s centralized, cloud-based library supports close to 200 different file kinds and gives a client total control over how company assets are stored, retrieved, and used.
FISION has completed the acquisition of Volerro Corporation (Minneapolis, Minnesota-based) following the announcement of a definitive purchase agreement on April 25, 2017. Volerro is a leader in cloud-based content collaboration and agile marketing technology.
Volerro enhances the FISION platform with complementary cloud-based collaboration, agile marketing, and sales enablement software. Volerro’s SaaS (Software as a Service) platform simplifies how enterprise teams create, refine, and distribute content.
Recently, FISION was awarded a U.S. patent (US9639551 B2) covering its cloud-based marketing technology called, “Computerized Sharing of Digital Asset Localization Between Organizations.”
FISION Chief Executive Officer, Mr. Mike Brown, said, “Our patented platform’s unique multi-tiered and multi-tenant functionality permits outside agencies and other marketing partners to securely access a company’s content repository, and create collateral materials that stays true to approved branding and messaging. It also provides administrators real-time visibility into the effectiveness of marketing and sales communication, measuring performance down to the individual asset and user level.”
FISION Corp. (FSSN), closed Wednesday's trading session at $0.1548, up 14.67%, on 72,792 volume with 19 trades. The average volume for the last 3 months is 154,778 and the stock's 52-week low/high is $0.0811/$0.259.
Asaleo Care Limited (ASLEF)
Penny Stock Tweets, Morningstar, Barchart, 4-Traders, Dividend Investor, Stockhouse, GuruFocus, MarketWatch, YCharts, The Street, Trade Ideas, Current Charts, Market Screener, TradingView, OTC Markets, Wallmine, Capital Cube and Wallet Investor reported earlier on Asaleo Care Limited (ASLEF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Established in 1932, Asaleo Care Limited is a leading personal care and hygiene Company. It manufactures, markets, distributes and sells essential everyday consumer products. These products cover the Feminine Care, Incontinence Care, Baby Care, Consumer Tissue and Professional Hygiene product categories. Asaleo Care is headquartered in Box Hill, Australia.
Asaleo Care is organized into three business units. These units are Consumer Tissue, Professional Hygiene, and Personal Care. Through its Consumer Tissue division, the Company manufactures and markets a number of leading consumer brands. These include Sorbent toilet and facial tissue, Handee paper towel, Deeko disposable tableware, Purex toilet tissue and Treasures nappies (New Zealand only).
Asaleo Care’s Professional Hygiene business delivers Tork hygiene solutions to the commercial, public, health care, food service and industrial segments. Through its Personal Care division, Asaleo Care manufactures and markets top personal hygiene products under the Libra feminine hygiene brand and the TENA incontinence brand. Asaleo Care supplies dispensers, paper towels, toilet tissue, soaps, napkins and industrial and kitchen wipers under the international Tork brand. Most of Asaleo’s brands hold number 1 or 2 market positions in Australia and New Zealand.
The Company also has its Pacific Islands initiative. Asaleo is well represented in the Pacific Islands via the distribution of a wide spectrum of Consumer Tissue, Tork Professional Hygiene and Personal Care products. In addition, Asaleo is well represented through the presence of a manufacturing site near Suva in Fiji. The Fijian plant produces toilet rolls, kitchen towels, serviettes, and facial tissues. The local brands Orchid and Viti are well known. These brands have market leadership in the Pacific Islands region.
Asaleo Care announced last month its partnership with REDcycle to decrease plastic packaging in landfills. Asaleo Care has partnered with REDcycle, which is a Melbourne based recycling organization that established a voluntary, industry-led initiative called the REDcycle Program. Furthermore, REDcycle is a signatory to the Australian Packaging Covenant.
The REDcycle program complements Asaleo Care’s partnership with the Tread Lightly program in New Zealand. This program educates school children about soft plastics recycling. It also establishes recovery systems in schools. Asaleo Care is also a member of the Love NZ Soft Plastics Recycling Scheme.
Asaleo Care Limited (ASLEF), closed Wednesday's trading session at $0.4616, down 3.71%, on 30,419 volume with 7 trades. The average volume for the last 3 months is 46,391 and the stock's 52-week low/high is $0.475/$1.34.
Integrated Cannabis Company, Inc. (ICNAF)
Awesome Penny Stocks, Wallstreet Online, Investors Hangout, MarketWatch, InvestorsHub, Stockwatch, Market News Updates, Wallet Investor, TradingView, The Venture Report, Market Chameleon, BioSpace, Stockhouse, OTC Markets, CannaBizNetwork, and Barchart reported earlier on Integrated Cannabis Company, Inc. (ICNAF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Integrated Cannabis Company, Inc.’s emphasis is health and creating health and lifestyle products using advanced delivery systems and formulations. The Company consists of dedicated scientists and product engineers. The Company was formerly known as CNRP Mining, Inc. It changed its corporate name to Integrated Cannabis Company, Inc. in June 2018. Integrated Cannabis Company is headquartered in Vancouver, British Columbia.
The Company’s X-SPRAYS™ product line consists of eight market ready orally ingested spray products. Four products available are infused with hemp-based cannabidiol (CBD). Four products are formulated without a cannabidiol (CBD) infusion. These products are highly bioavailable; the active ingredients in the sprays are already fully dissolved. Consequently, the vitamins and minerals do not need to be further broken down once swallowed. They are immediately available for use by the body.
The X-SPRAYS™ product line is packaged in precise, metered dose and convenient spray tubes. This includes a child-resistant version. Integrated Cannabis Company’s CBD is hemp derived from Colorado. Its products are made in Arizona.
Integrated Cannabis Company announced in September 2018 the completion of a market ready Tetrahydrocannabinol (THC)-infused spray product and the required licensure for manufacturing of the product in Colorado. The THC product uses the same nanotechnology used to enhance the CBD-infused X-SPRAYS™. This results in higher bioavailability and speedier uptake versus capsules or powder. Integrated Cannabis continues to enhance the flavor profiles so as to find an ideal formula.
Earlier in November, Integrated Cannabis Company announced the completion of a Definitive Agreement to distribute X-SPRAYS™ products throughout the clinics and doctors' offices of Empower Clinics, Inc. Empower is a leading owner and operator of medical cannabis and wellness clinics in the United States. Moreover, Integrated Cannabis has received its initial purchase order from Empower for a selection of X-SPRAYS™ products.
Today, New Age Brands announced that New Age Brands’ fully-owned subsidiaries, We Are Kured, LLC and Drink Fresh Water LLC, have teamed up with Integrated Cannabis and their X-SPRAYS™ product line, to bring a unique CBD concept to the Colorado X Games on January 25 – 27, 2019. As of last week, the City of Aspen approved the first ever CBD pop-up retail store in their city limits. Kured, Fresh Water and X-SPRAYS™ have approval to sell their products to consumers over the age of 18+ out of the Bootsy Bellows event center in the heart of Aspen, Colorado.
Integrated Cannabis Company, Inc. (ICNAF), closed Wednesday's trading session at $0.4169, up 9.71%, on 339,955 volume with 198 trades. The average volume for the last 3 months is 660,294 and the stock's 52-week low/high is $0.209/$1.58.
The QualityStocks Company Corner
- Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF)
- Cannabis Strategic Ventures, Inc. (NUGS)
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
- Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)
- Generation Alpha, Inc. (GNAL)
- Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G)
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ)
- First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF)
- Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)
- Marijuana Company of America Inc. (MCOA)
- Pressure BioSciences Inc. (PBIO)
- RYU Apparel Inc (TSX.V: RYU) (OTC: RYPPF) (FRA: RYA)
- Sugarmade, Inc. (SGMD)
- Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4)
Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF)
Progressive medical device technology company Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) recently detailed its plans to incorporate a 100 percent wholly owned subsidiary to hold device-related technology for the application or use of medicinal or recreational marijuana, including its previously-detailed pain relief device and all related intellectual property. To view the full press release, visit: http://cnw.fm/6wyQw.
Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) is a medical device technology provider focused on addressing dermatological needs in the multi-billion-dollar cosmeceutical industry. The company’s effective, non-invasive and pain-free skin care is based on proprietary technology which has received Class II medical device status from the U.S. Food and Drug Administration.
Therma Bright’s portfolio includes products, devices and treatments that have both cosmetic and medicinal or therapeutic benefits, such as for relief of pain, itch and inflammation resulting from more than 20,000 types of insect and marine life bites and stings, including bees, wasps, hornets, mosquitos, black flies and jellyfish.
The Company’s current focus is to market its products online through various social media networks, and to eventually re-establish relationships with major North American and Global retailers.
The company currently has two products on the market and another in the research and development phase:
InterceptCS™ is a thermal therapy device for the treatment and prevention of cold sores caused by the herpes simplex Type 1 virus*. Symptoms typically include sores around the mouth and lips which InterceptCS™ treats by application of controlled topical heat with no risk of burning the skin. When used at the first sign of an oncoming cold sore application of InterceptCS™ can prevent symptoms from developing. Infrared energy and light from the device penetrate the skin killing cells infected with the virus.
InterceptCS™ is available without prescription and comprises a battery powered ergonomic hand-held unit and a disposable single-use treatment activator. Therma Bright has completed prototyping of multi-use activators for InterceptCS™. The company plans to bring to market 5, 10 or 20 multi-use activations at prices that will offer customers greater value than the current single-use activator.
The other Therma Bright product currently under development is TherOZap™, a next generation thermal therapy device powered by the company’s core technology, which is approved by the FDA as a Class II medical device for the relief of the symptoms of insect bites. Therma Bright is testing a new easier-to-use prototype of the device for effectiveness against Zika virus and other diseases carried by mosquitos. Once the technology proves effective, Therma Bright intends to seek regulatory approvals and extend the prototype enhancements to a new commercial version of TherOZap™.
Therma Bright is also conducting research and development on a unique thermal therapy device that would incorporate medical grade cannabis or cannabidiol (“CDB”) sourced from hemp as a cream or gel to provide relief of back, knee and other joint pain. In preparation, the company has incorporated a wholly owned subsidiary to hold any technology for use or application of cannabis. Once approvals are secured, the company plans to sell the device through licensed cannabis producers or retailers across Canada and in international markets where use of cannabis has been legalized. The company has initiated trademark and patent protection for its thermal therapy technology incorporating medical cannabis. Therma Bright has indicated it will seek an acquisition to help further development of this product.
A report by market intelligence firm Mordor Intelligence put the global cosmeceuticals market at a value of nearly US$47 billion in 2017 and projects it to be worth more than $80 billion by 2023, growing at a rate of almost 9.5 percent annually. Medical research estimates that somewhere between 20 percent and 40 percent of the population suffer occasional cold sore outbreaks. In Canada those figures would mean five to 10 million people, and in the U.S. some 40 million to 80 million, with recurring cold sores, representing a substantial potential market for Therma Bright.
Rob Fia serves as Therma Bright chairman and CEO. Fia has extensive contacts in the investment community and the financial sector as well as knowledge of various Canadian stock exchange listing processes and requirements. His 18 years in the investment business has included equity research and advising promising early stage companies on corporate finance. Therma Bright CFO Victor Hugo is a senior financial analyst at Marrelli Support Services Inc., for which he provides CFO, accounting, regulatory compliance, and management advisory services to companies listed on the TSX, TSX Venture Exchange and other Canadian and US exchanges.
**Based on double blind placebo study, the InterceptCS™ is approved by Health Canada for the claim “For prevention of cold sores when used within 3 hours of the onset of the prodrome.” The InterceptCS™ is not approved by the United States FDA or any claim of clinical indication, clinical efficacy, and/or cure or prevention of disease.
Therma Bright, Inc. (OTC: THRBF), closed the day's trading session at $0.029, even for the day. The stock's 52-week low/high is $0.0256/$0.029.
- CannabisNewsBreaks – Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Details Plans for Cannabis Device-Focused Subsidiary
- Therma Bright Inc. to Establish Subsidiary for Cannabis Related Devices
- Therma Bright Engages Top Virology Research Group to Conduct Further Tests of TherOZap(TM) Technology Against the Zika Virus
Cannabis Strategic Ventures, Inc. (NUGS)
Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) is pleased to announce that portfolio client Biolog Inc. has formed a partnership with Cannabis Strategic Ventures, Inc. (OTC:NUGS), to develop water-soluble cannabis technologies to be used as ingredients for cannabis and phytocannabinoid rich-infused foods, beverages and consumer products. Also today, CannabisNewsWire released a report highlighting the company which examines the recent news that a team of researchers interested in finding out whether cannabis could treat PTSD (post-traumatic stress disorder) among veterans finally registered its 76th study participant on Veterans Day.
Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.
The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.
Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.
Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.
Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.
Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.
Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.
The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.
Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $1.93, up 2.12%, on 54,391 volume with 111 trades. The average volume for the last 3 months is 63,081 and the stock's 52-week low/high is $0.032/$7.13.
- Redfund Capital Client Biolog Inc. and Cannabis Strategic Ventures Inc. Announce Joint Development of Water-Soluble Cannabis Technology
- 420 with CNW – Cannabis PTSD Study Finally Secures Target Number of Participants
- NetworkNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Seeking Out Cultivation Facilities with Existing Infrastructure
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) introduction of ChrgD+ powder packets, which can add multi-spectrum hemp oil to any hot or cold drink, leverages the trademarked ability of the company’s DehydraTECH to deliver cannabinoids. LXRP’s partnership with Cultivating Wellness Inc. (“CW”), which formulated the product, is seen as an important combined effort (http://nnw.fm/2wweW). Also today, CannabisNewsWire released a report highlighting the company which examines the recent news that Canada is legalizing cannabis across the board, Mexico is fast-tracking legalization, and industrial hemp appears to be headed for legalization in the United States thanks to landslide approval in the Senate (86 to 11) of its version of the new hemp-friendly Farm Bill.
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.
The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.
In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.
Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.
Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.
Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.
Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.06, up 1.44%, on 164,532 volume with 230 trades. The average volume for the last 3 months is 235,687 and the stock's 52-week low/high is $0.741/$2.54.
- Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Mobile Hemp Oil Supplement Powder Packet, ChrgD+, Utilizes DehydraTECH Technology
- Booming Cannabis Consumables Space Continues to see Product Innovations
- Lexaria Bioscience Submits Application to Health Canada for Research License and Appoints Chief Legal Officer
Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)
Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF), a hemp-cultivated cannabinoid innovator, believes that the best approach to maintaining health is to use ancient Eastern traditions of whole plant medicine with modern Western principles of naturopathic science. The company has developed products that promote a busy, active lifestyle through the use of natural plant-based ingredients that fuel and energize the body.
Headquartered in Vancouver, Canada, with operations offices in southern California, Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF) is a premium food and beverage company that develops CBD-infused functional foods, beverages and supplements poised for global distribution. All products in the Phivida label are infused with organic, hemp-derived cannabinoids into a variety of premium foods, beverages and clinical products for everyday health. Phivida is guided by a team of Fortune 500-caliber executives focused on a new strategic portfolio of products and brands, comprehensive consumer research, new product and brand development, improved visual identity and packaging design, and a strong distribution strategy.
The company’s motto – “Celebrating Health and Wellness, in Harmony™” – underscores Phivida’s mission to lead the alternative health care sector as the benchmark standard in premium CBD-infused functional beverages and tinctures. To execute this goal, Phivida is taking advantage of positive legislative developments in the United States and has defined an elevated national route-to-market strategy across the U.S. where small regional distributors will be now be replaced with large national distributors.
Phivida’s management team includes president and CEO Jim Bailey, former president of Red Bull Canada and global chief marketing officer for Merrell Outdoors; Chief Marketing Officer Michael Cornwell, former chief marketing officer for Samsung New Zealand and the former director of marketing for Red Bull Canada; and Doug Campbell, former director of sales for Red Bull North America, who as Phivida’s chief commercial officer is tasked with driving new sales revenue growth.
Publicly traded on the Canadian Securities Exchange (CSE.VIDA) and recently graduated to the OTCQX Best Market in the USA (OTCQX.PHVAF), the company’s strong balance sheet carries CAD$15.7 million with no debt or loans with less than 60 million shares outstanding and the company is now well-capitalized to fun major mainstream distribution with a solid structure poised for long-term growth.
Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold.
Encapsulated CBD is infused into functional beverages, food and supplements containing a proprietary blend of phytonutraceuticals studied to target a range of health and wellness conditions. Phivida tests every product for microbials, heavy metals, pesticides, residual solvents, terpenes, and potency to guarantee less than 0.3 percent THC (tetrahydrocannabinol, the chemical compound in cannabis responsible for a euphoric high) is present.
Federally legal under the 2014 Farm Bill, CBD from Hemp Oil is a rapid growth market across the USA. When derived from marijuana, CBD remains a schedule one controlled substances, giving hemp derived CBD oil infused products a competitive advantage on regulations. On June 28, 2018, the U.S. Senate passed the Agriculture Improvement Act of 2018 (i.e. the “Farm Bill), lifting the USA Industrial Hemp laws to an agricultural commodity status and effectively removed hemp from the controlled substance list.
Earlier this year, another milestone court ruling also provided significant regulatory support for the US CBD-Hemp sector. In February 2018, the Supreme Court preceded over the HIA (Hemp Industry Association) vs. DEA (Drug Enforcement Agency) in a class-action suit concerning the issue of CBD extracted from hemp, and the legality of industrial hemp. In the final ruling the Supreme Court unequivocally determined that – when produced domestically under the Farm Bill – hemp (and its derivatives) are not a controlled substance.
The Supreme Court ruling also found the Farm Bill (as it relates to hemp) “pre-empts” the Controlled Substances Act. Congress has since exempted Farm Bill hemp from the Controlled Substances Act (CSA) giving the Farm Bill primary jurisdiction over the governance of the CBD-Hemp Oil industry in the USA.
The DEA further conceded it does not “seek to control cannabinoids,” and that only marijuana derived cannabinoids are governed under the Controlled Substances Act. In May of 2018, the DEA issued a formal directive to all federal agencies (e.g. US Customs and Border Patrol) stating that cannabinoids are not controlled substances unless derived from marijuana, and that the “mere presence of cannabinoids” in any product or derivative does not render it a controlled substance. The Supreme Court ruling also resulted in the mediation of a settlement in what is now the third successful HIA vs. DEA suit in over a decade.
In Canada, the Senate approval of Bill C-45 legalized the production, distribution and use of recreation cannabis – with edibles to be added in 2019. The bill will officially become law as of October 17, 2018, creating a legal framework for the production, distribution, sale and possession of cannabis across Canada including cannabinoid-infused beverages.
3 Wholly Owned Subsidiaries
- Phivida Organics Inc. offers professional-grade, wholesale, whole plant hemp oil extracts made from 100-percent certified organic hemp stalk. Phivida’s hemp oil extracts are CO2-extracted under quality assurance/clinical standards and are third-party lab tested to assure only pharmaceutical grade, cGMP certified, full-spectrum products are produced and available for sale. Phivida Organics produces hemp oil extracts that deliver nano-encapsulated cannabinoids in water soluble formulations designed to be absorbed up to 10 times faster than other oils, providing up to 400 percent bioavailability. Phivida Hemp Oil Vida+ extract products are available now online at www.Phivida.com.
- Phivida Nutrition blends the best of nature into CBD-infused lifestyle branded beverages including a variety of CBD infused iced teas and CBD infused flavored waters.
- Phivida Enhanced – Under the VIDA brand, CBD-infused tinctures, capsules and other supplement products are distributed to alternative health care clinics across the USA.
Phivida has signed a binding letter of intent to joint venture WeedMD Inc. (TSX-V: WMD) (OTC:WDDMF) (FSE:4WE), a Health Canada federally licensed producer and distributor of medical cannabis, to form a joint venture focused on cannabis-infused beverages. The new joint-venture company, Cannabis Beverages Inc. (“CanBev”), plans to develop a production facility at WeedMD’s state-of-the-art greenhouse facility in Strathroy, Ontario, Canada. CanBev is on track to build and operate the first cannabis-infused beverage production facilities in Canada. The joint venture will focus on manufacturing, marketing and distribution of cannabinoid-infused beverages for the legalized medical and adult-use cannabis markets.
Management from both WeedMD and Phivida are collaborating on design and engineering strategies and site evaluations on a 610,000-square-foot, state-of-the art facility in Strathroy for the development of CanBev. As an emerging certified food grade production plant, the Strathroy facility is an ideal location and comes is equipped with extensive production infrastructure, including 50,000 sq. ft. of food production and packaging area, cold storage, loading docks, and adequate space to expand for future growth.
Phivida Organics has also entered into an agreement to carry out a pharmacokinetic (PK) study on its hemp-derived, nanoencapsulated CBD with Artelo Biosciences Inc. at the University of Nottingham, School of Medicine at the Royal Derby Hospital, England. The study will test encapsulated-CBD on healthy volunteers and measure how fast and how much CBD enters the blood stream after oral consumption with each of the different formulations developed by Phivida Organics.
Phivida has also activated distribution agreements with Asayake Inc. to become one of the first federally approved CBD-infused food and supplement brands in Japan. With first mover status achieved, Phivida now markets to an underserved, yet highly informed population of 127 million patients and practitioners. The supplement market in Japan is estimated at US$10 billion with the overall functional foods market at US$21 billion. The Asia-Pacific region is the fastest growing market for natural plant-based supplements. Phivida now plans to prepare a formal application to Japan’s Consumer Affairs Agency to register the company’s CBD-infused functional food and beverage products for approval under the country’s Food with Functional Claims regime. The functional beverage market in Japan is estimated at US$10.35 billion with a CAGR of 2.5 percent (2015-2025).
+1 (844) 744-6646 (ext. #2)
Phivida Holdings Inc. (PHVAF), closed the day's trading session at $0.5403, up 16.19%, on 50,247 volume with 30 trades. The average volume for the last 3 months is 114,834 and the stock's 52-week low/high is $0.05/$1.80.
- Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Uniquely Meeting Niche Market Needs
- NetworkNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Provides Corporate Business Update for Q4 2018
- NetworkNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Sees Promising Future Following the Removal of CBD from Schedule 1 List of Controlled Substances
Generation Alpha, Inc. (GNAL)
Generation Alpha, Inc. (OTCQB: GNAL), a vertically integrated cannabis technology innovator, manufacturer and distributor, today announced that Alan Lien, Chief Executive Officer, and Tiffany Davis, Chief Operations Officer, will present at the 11th Annual LD Micro Main Event investor conference at 12:30 pm PT on Wednesday, December 5, 2018 at the Luxe Sunset Boulevard Hotel in Los Angeles, California. The conference will be held December 4-6, 2018.
Generation Alpha, Inc. (GNAL) was established in 2010 as a vertically integrated technology innovator, developer, manufacturer and distributor focused on bringing products and solutions to both commercial and individual growers in the United States. Originally named Solis Tek Inc., the company changed its name to Generation Alpha in September 2018 and announced an increased focus on providing innovative and must-have cannabis products and services to a growing industry.
“Generation Alpha for us means ‘new beginning’” said Generation Alpha CEO Alan Lien, when the name change was announced. “It is the new wave of how people and brands connect. We are excited with the transformation of our business strategy, our progress at our Arizona facility and the additional growth opportunities our team has identified elsewhere in the cannabis industry. While we are pleased with our innovation and progress in our Solis Tek lighting and Zelda Horticulture divisions, we believe?Generation Alpha?represents our philosophy of bringing the best cannabis products and services to the market. We are confident that this shift in our business strategy will create long-term shareholder value through diversified segments in the legalized cannabis industry.”
The name change reflects the company’s strategy to leverage business opportunities in different legalized cannabis spaces, including cultivation, processing and retail facilities. As part of that focus, Generation Alpha acts as the holding entity for a collection of companies that bring products and solutions to legal retail and commercial cannabis growers while utilizing its expertise to offer safe, quality and consistent products through its cultivation, processing, and retail facilities as well as branded products in both the medical and recreational markets. Along with its strong focus on the burgeoning cannabis market, Generational Alpha remains committed to developing and providing innovative products and services in both Solis Tek Digital Lighting, its lighting division, and Zelda Horticulture, its agricultural products division.
As part of a key piece of its cannabis focus, Generation Alpha acquired a cannabis cultivation and processing facility in Phoenix, Arizona, which is scheduled to begin operation in 2019. Currently in the design and development stage, the 70,000-square-foot facility will be one of the most technologically advanced cultivation and processing facilities in Arizona, which is a hot bed of cannabis cultivation in North America. Generation Alpha management is confident about the growth and profitability this facility provides as an essential component of its forward-thinking cannabis strategy.
Additional components of this strategy include the company’s GrowPro Solutions, Inc., a nationwide cannabis cultivator and processor and a variety of Generation Alpha brands, which include the innovation, design and selling of cannabis?products such as flower, oils and accessories in the legal medical and recreational markets.
The company’s Zelda Horticulture division offers commercial-grade rolling tables, greenhouses, PH stabilizer and nutrient products, and other agricultural products for cultivators around the world. Zelda’s custom-design cultivation options means its clients can count on increased agricultural productivity and efficiency.
Generation Alpha’s Solis Tek Digital Lighting division offers an extensive line of lighting equipment and accessories, including digital ballasts, reflectors,?complete lighting systems, single- and double-ended digital lamps, controllers and other accessories.?Each product is designed to help retail and commercial growers maximize quality and achieve higher yields and maximize quality.?
Generation Alpha, Inc. (GNAL), closed the day's trading session at $0.459, up 2.00%, on 23,652 volume with 25 trades. The average volume for the last 3 months is 66,332 and the stock's 52-week low/high is $0.40/$2.64.
- Generation Alpha to Present at LD Micro 11th Annual Main Event Investor Conference on December 5, 2018
- CannabisNewsBreaks – Why Generation Alpha, Inc. (GNAL) is “One to Watch”
- CannabisNewsAudio Announces Audio Press Release (APR) on Generation Alpha, Inc. Positioning to Cultivate Opportunity in Booming Cannabis Sector
Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G)
Sproutly Canada, Inc. (CSE:SPR) (OTCQB:SRUTF) (FSE:38G) (“Sproutly" or the “Company”) is pleased to announce that Michael Bellas, CEO and founder of Beverage Marketing Company (www.beveragemarketing.com) has joined the Company’s board of directors. Mr. Bellas is a seasoned beverage executive who brings over 45 years of experience working with leading beverage companies across all beverage categories.
Sproutly Canada, Inc. (OTC: SRUTF) (TSX.V: SPR) (FRA: 38G) is developing and bringing to market cannabis consumer products with a focus on beverages. The company’s core mission is to become the leading supplier of water-soluble cannabis solutions and bio-natural oils for brands in the emerging cannabis beverage and edibles market.
To make this happen, Sproutly acquired Infusion Biosciences to bring to market a patent-pending Aqueous Phytorecovery Process (APP) technology, a fundamental paradigm shift within the cannabis industry. Replacing traditional water-compatible solutions with true natural water solubility improves the body’s ability to utilize cannabinoids, making the effect of the cannabis almost immediate.
This revolutionary process doesn’t alter the cannabis compounds and provides an onset time and offset time that mimics the same effects as inhaled marijuana. That means consumers may feel effects in five minutes or less and be free from the desired effect in approximately 90 minutes—a vastly different ingestion pattern than current methods. In addition, the water-based cannabinoids can be mixed with other liquids and stay dissolved in those liquids. The application of water-soluble cannabis infusions has potential to be widespread in both medicinal and recreational cannabis sectors, giving Sproutly a distinctive edge in a market with untapped potential.
Sproutly’s business model is focused on processing rather than cultivating, which means its success is not constrained to growing its own cannabis. The company does own a Toronto-based, ACMPR-licensed facility designed and built with a focus on cultivating pharmaceutical-grade cannabis to produce and formulate the first natural, truly water-soluble cannabis solution. Its water-soluble ingredients and bio-natural oils will deliver revolutionary brands to international markets that are searching for well-defined commercial products.
Sproutly’s entrance in the cannabis market is perfectly timed as cannabis is moving towards mainstream acceptance. Potential users are, however, interested in consuming cannabis products as drinks and using it as oils rather than smoking. The potential cannabis beverage market is staggering, and with Sproutly owning the exclusive rights to APP technology in Canada, Australia, Jamaica, Israel and the entire European Union, the company is looking at significant international expansion opportunities.
Sproutly plans to capitalize on these international opportunities by executing on partnerships with local and globally established consumer brands to leverage their existing customer bases, expand brand loyalty, and assist with marketing and support distribution networks to deliver scientific breakthroughs with speed and efficiency?worldwide.
Sproutly believes that talent drives growth. The company is committed to bringing together the best and brightest minds in the cannabis space to help with their mission to disrupt the global beverage and consumables market.
President, CEO and Director Keith Dolo recently served for more than 13 years with Robert Half, an S&P 500, NYSE-listed company. At Robert Half, Dolo held the position of vice president for more than eight years, as well as other senior roles in both operations and sales. He also sits on an advisory committee and a board position for two nonprofits in Vancouver, BC.
Chief Science Officer and Director Dr. Arup Sent has more than 35 years of experience in research and executive management at biotechnology and pharmaceutical companies. He was awarded a PhD in biochemistry from Princeton University and is a former faculty member at the National Cancer Institute and Scripps Research Institute. Sen is the inventor on five U.S. patents and numerous international patents and patent-pending applications.
Chief Financial Officer Craig Loverock is a chartered professional accountant with over 20 years of experience in accounting and finance roles in Canada, the United States and the United Kingdom. He has extensive expertise in public company reporting and transactional experience, having served as the senior financial advisor to the chairman at Magna International and acting as chief compliance officer and CFO for a private equity firm.
Head Grower Frank Han has over 12 years of experience in the horticulture industry. A previous master grower in a large commercial facility, Han has impressive expertise in all growing methods, techniques and procedures. He brings with him a wealth of knowledge in cloning, nutrient and overall plant management. Han will be in charge of the production team at Sproutly’s Toronto Herbal Remedies facility.
Sproutly Canada, Inc. (OTC: SRUTF), closed the day's trading session at $0.248, up 20.04%, on 325,939 volume with 129 trades. The average volume for the last 3 months is 137,940 and the stock's 52-week low/high is $0.189/$1.875.
- Sproutly Adds Seasoned Beverage Executive Michael Bellas to the Board of Directors
- Sproutly Canada, Inc. Subsidiary, Toronto Herbal Remedies, Receives License to Sell to Other Licensed Producers and Expands Growth Production Footprint
- Chief Science Officer, Dr. Arup Sen of Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) at Podcaster Row, MJBizCon, Talks about Unique Water-Soluble Technology and the Ability to Create Designer Cannabis Beverages
QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)
QMC Quantum Minerals’ (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Irgon Lithium Mine was previously explored during the 1950s. The recent immense global demand for lithium implored QMC to rediscover the mine and initiate the continuation of exploration and development work there. To view the full article, visit: http://nnw.fm/bX7ks.
QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.
QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.
The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.
North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.
The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.
QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens, and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.
The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.
QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.2046, up 4.02%, on 35,915 volume with 27 trades. The average volume for the last 3 months is 99,284 and the stock's 52-week low/high is $0.168/$1.46.
- NetworkNewsBreaks – QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Using Historic Exploration to its Advantage
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Set on Developing Manitoba’s Full Lithium Production Potential
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Advances Lithium Project
First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF)
Vertically integrated North American pure-play cobalt company First Cobalt (TSX.V: FCC) (OTCQX: FTSSF) (ASX: FCC) remains confident as it finds growing resource potential at its flagship project in Idaho. A recent article discussing the company reads, “The company is working to extend the strike length and down dip depth by at least double their current measures. To view the full article, visit: http://nnw.fm/D0y1o.
First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.
First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.
First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.
First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.
The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.
First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.
First Cobalt Corp. (FTSSF), closed the day's trading session at $0.19, up 8.57%, on 175,139 volume with 38 trades. The average volume for the last 3 months is 187,278 and the stock's 52-week low/high is $0.1382/$1.289.
- NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Classifies Iron Creek Project as an Advanced, Unique Cobalt Asset
- NetworkNewsBreaks – First Cobalt Corp.’s (TSX.V: FCC) (OTCQX: FTSSF) Flagship Iron Creek Project Shows Continuity of Mineralization
- First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Begins Tests to Restart Only North American Refinery Capable of Producing Battery-Grade Cobalt
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF)
Chemistree Technology Inc. (Canadian Securities Exchange: CHM) (US OTCQB: CHMJF) (the "Company" or "Chemistree") is pleased to announce that its common shares are now eligible for electronic clearing and settlement through the Depository Trust Company ("DTC") in the United States. Also today, CannabisNewsWire released a report on the company detailing how the unique state-by-state approach to legalization in the U.S. has provided Chemistree Technology with an ideal environment to build its brands through the production and sale of premium cannabis in California and Washington. It has also shielded American companies from an influx of foreign product.
Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF) an investment company focused on the U.S. and international cannabis sectors, provides turnkey solutions for the regulated cannabis industry. The company leverages managements’ expertise and decades of experience in the cannabis industry to acquire and develop vertically integrated cannabis assets. Chemistree recently closed on a purchase of prospective cannabis cultivation property in California, made a first investment in the Canadian cannabis industry, owns assets in the State of Washington used to operate an established retail cannabis brand, and has an active pipeline of assets in place to grow its portfolio.
Chemistree offers industry leading expertise across all areas the cannabis business and in its growth as a public or private company
- Investment and funding for rapid growth
- Vertical integration solutions
- Construction, design and/or optimization of indoor or outdoor cultivation facilities
- Reputation management & influencer outreach
- Branding and Packaging
- Social Media and Media outreach
With the marketing of cannabis companies and their products in its infancy, the company believes the industry offers tremendous opportunity for growth in the U.S. and abroad. Chemistree initially targeted the Pacific Northwest for investment and, following its recent California property purchase, expects to expand vertically across the United States in areas where it has a competitive business advantage.
Through its wholly owned CHM Desert LLC subsidiary, Chemistree owns 9.55 acres of undeveloped land in Desert Hot Springs, California. The property is zoned as Light Industrial Lands Designated for Marijuana Cultivation, and local zoning ordinances allow as a conditional use the location of up to three onsite cannabis cultivation buildings of 68,000 square feet each, along with support space that would support production of 55,000 pounds/year.
Through its wholly owned Chemistree Washington Ltd. subsidiary, Chemistree acquired physical assets used in the cultivation, production and distribution of cannabis. The Washington assets are currently under lease to Sugarleaf Farm LLC, which operates the Sugarleaf brand of retail cannabis products in the State of Washington. Sugarleaf Farm is a Tier 3 cannabis producer and processor whose products are sold in about 125 retail outlets. Chemistree has indicated the relationship with Sugarleaf may provide the company with additional opportunities to become involved in the marketing of Sugarleaf products.
Chemistree funded these acquisitions and investments with the proceeds of two non-brokered private placement financings completed earlier this year under the regulations of the Canadian Securities Exchange, totaling CAD$4.5 million. In conjunction with the private placements, the company was granted approval by the CSE for a change of business to become an Investment Issuer. This funding is expected to provide the company “maximum flexibility to take advantage of the numerous opportunities available in the cannabis industry in Canada and the U.S.”
Chemistree also has a strategic investment in Pasha Brands Ltd., a British Columbia based cannabis company with multiple internationally recognized brands. Pasha has a proven history in cannabis retailing and its proposed Licensed Processing (LP) facility on Vancouver Island is in the final stage of the application for government approval. The LP facility is expected to assist in licensing selected craft growers of cannabis and expanding the distribution of locally grown product. The investment represents less than 10% of Chemistree’s working capital.
Company Chairman Justin Chorbajian is co-owner of the largest chain of privately owned hydroponic retail shops in Canada. He also cofounded a group of companies that manufacture and distribute hydroponic equipment. He is a frequent contributor to Growing Exposed, the leading video series dedicated to cannabis cultivation. Company President Karl Kottmeier is a former investment advisor with 20 years of experience listing, financing and administering companies on the Toronto Stock Exchange and TSX Venture Exchange. He has raised more than $150 million in equity capital for ventures. Chemistree CFO Doug Ford has been general manager of Dockside Capital Group Inc., a private merchant banking and venture capital firm serving emerging growth companies. Sheldon Aberman, the most recent member of the Board, has managed, designed and created industry leading grow room designs around the world. Additionally, he has built several leading brands such as Frost Box and Black Label and is an expert in the accessory market (vape pens, silicon mats and extraction tools etc.).
Data firm Statista has forecast the U.S. legal cannabis market will be worth more than $24 billion by 2025. New Frontier Data, which focuses exclusively on the cannabis industry, projects the value of the Canadian domestic cannabis market that same year at CAD$9.2 billion.
Chemistree Technology Inc. (CHMJF), closed the day's trading session at $0.334, off by 1.76%, on 34,236 volume with 40 trades. The average volume for the last 3 months is 2,882 and the stock's 52-week low/high is $0.268/$0.7158.
- Chemistree Announces DTC Eligibility
- CannabisNewsWire Announces Savvy Investors Assessing U.S. Market Amid Canada’s Cannabis Boom
- Chemistree Partners With Humboldt County, California Cannabis Processor
Marijuana Company of America Inc. (MCOA)
CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Marijuana Company of America, Inc. (OTC: MCOA), a client of CNW that focuses on product research and development of legal hemp-based consumer products containing CBD under the brand name "hempSMART", an affiliate marketing program to promote and sell its products, as well as leasing of real property and expansion of business into ancillary areas of the legalized cannabis and hemp industry. To view the full publication, titled “Departure of US AG and Democratic House Control Improve Prospects for Hemp Industry,” visit: http://cnw.fm/NpUA5.
Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.
The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.
The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.
The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.
Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.
Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0179, off by 1.38%, on 10,644,531 volume with 305 trades. The average volume for the last 3 months is 9,375,295 and the stock's 52-week low/high is $0.0166/$0.073.
- CannabisNewsWire Announces Recent Washington, D.C., Changes Pave Way for Opportunity for Hemp and Cannabis Producers
- Harvest Update at Marijuana Company of America’s CBD Hemp Project in Scio, Oregon
- Expansion of CBD – Hemp Operations Continues to Explode as Demand and Sales Revenues Climb
Pressure BioSciences Inc. (PBIO)
Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform solutions, this morning announced that President and CEO Richard T. Schumacher was recently interviewed by broadcast journalist Christine Corrado of Proactive Investors, a leading multi-media news organization, investor portal and events management business. To view the video interview, visit http://nnw.fm/25A6i. To view the full press release, visit: http://nnw.fm/1sPzW.
Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.
The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.
Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”
Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.
The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.
Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.
This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.
The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.
Pressure BioSciences Inc. (PBIO), closed the day's trading session at $2.42, off by 2.02%, on 18,638 volume with 37 trades. The average volume for the last 3 months is 2,923 and the stock's 52-week low/high is $2.45/$5.00.
- CannabisNewsWire Announces Recent Washington, D.C., Changes Pave Way for Opportunity for Hemp and Cannabis Producers
- Pressure BioSciences Joins Uptick Newswire's Stock Day Podcast to Share the Achievement of Another Important Milestone in the Development of Its Proprietary Ultra Shear Technology Platform
- Pressure BioSciences Achieves Second Major Milestone in the Development of Its Ultra Shear Technology Platform
RYU Apparel, Inc. (TSX.V: RYU) (OTC: RYPPF) (FRA: RYA)
RYU Apparel Inc. (TSX VENTURE: RYU.V, OTCQB: RYPPF), creators of urban athletic apparel, celebrates its flagship opening in Williamsburg with a capsule collection highlighting four local New York artists. Curated by NYC graffiti legend, Stash, the collaboration includes four graphic tees and sweatshirts featuring the word "Respect," designed by Futura, CES, WANE, and Stash in each artist's signature aesthetic.
Engineered for the fitness, performance and lifestyle of the athletically-minded, RYU Apparel, Inc. (DBA RYU \ Respect Your Universe) (TSX-V: RYU) (OTC: RYPPF) (FRA: RYA) develops, markets and distributes apparel, bags and accessories for active people living their lives with integrity. Headquartered in Vancouver, Canada, with with four stores located in Greater Vancouver Area, British Columbia and one in Toronto, RYU opened its first U.S.-based store at the iconic Abbot Kinney Boulevard in Venice California, on August 2, 2018. Additional retail locations are slated to open soon in Etokicoke, Ontario, Canada; Brooklyn, New York; and Newport Beach, California, with plans to establish nearly two dozen more store locations by the end of 2022.
Respect Your Universe’s award-winning brand celebrates, encourages and respects an individual’s choices and journey in life, promoting a fitness lifestyle culture. Innovatively designed without compromise and tailored for fit, comfort and durability, RYU exists to facilitate human performance. RYU’s urban athletic apparel and accessories product line has been featured by some of the most influential fitness and outdoor lifestyle publications and social media connectors.
The company recently was honored in Madrid, Spain, as a 2018 Finalist in the World Retail Awards in the categories of “Retail Start Up of the Year” and “Social Media Campaign of the Year,” (#RYUOneMoreRep). RYU is one of only two Canadian companies that qualified as finalists among many global retailers across all categories of the World Retail Awards annual event. The World Retail Awards have been recognizing the very best retailers and retail initiatives across a range of categories since 2007.
Marcello Leone, CEO of RYU, said the company’s inclusion in the prestigious lineup of finalists was gratifying, stating, “Being chosen by the World Retail Awards is a fantastic accolade. We are proud to be among a group of global peers that are considered to become the next generation of iconic brands. #RYUOneMoreRep Media Campaign is also another confirmation of the social aspect that permeates our brand and the impact we are having in our community.”
In addition to its retail locations, RYU generates sales through its e-commerce platform and has developed strategic relationships with companies such as Global-E, Netamorphosis, Fancy and the NHL Vancouver Canucks to expand its reach. RYU is also building connections with influential leaders and social media influencers who represent the company’s values of aliveness, bold expression, curiosity, discipline and respect. Under RYU’s Connector Program, each leader actively engages in community charities, volunteer efforts and participates in charity programs. Among the famous personalities and community leaders connecting with the RYU brand are:
- Alexandra Ianculescu, a Canadian National Team Olympic Speed Skater
- Ben Carr, professional trainer
- Tori Katongo, personal trainer, singer, actor, dancer
- Simon “Thor” Damborg, head coach at Raincity Athletics
- Cassie Hawrysh, a Canadian National Team Skeleton Racer
- Dai Manuel, lifestyle mentor and author of “The WholeLife Manifesto”
Company CEO Leon is the founder of Naturo Group Investment Inc., a company that sells nutritional beverages, and also is the former VP of operations and president of LEONE, an independent high fashion specialty store in Vancouver, Canada. Chief Financial Officer Pedro Villa is a certified CPA who has held several senior positions in various North American companies. Brett Pawson, senior VP of retail and operations, has more than 15 years of experience in sales and operations in the wellness, consumer goods and retail sectors.
RYU’s strategic focus is on becoming a global leader as a fitness and training apparel and accessories brand for athletes in multiple disciplines. RYU’s goal is to facilitate human performance by honoring and celebrating the extraordinary oneness of humanity by respecting each other’s differences – Respect Your Universe.
RYU Apparel, Inc. (RYPPF), closed the day's trading session at $2.42, off by 2.02%, on 68,060 volume with 9 trades. The average volume for the last 3 months is 125,810 and the stock's 52-week low/high is $2.45/$5.00.
- RYU announces "Respect" collaboration featuring designs from local artists
- RYU Listed in Prominent Media Publications
- RYU CEO Marcello Leone Broadcasts Live from the New York Stock Exchange to Announce Opening of Flagship NYC Store
Sugarmade, Inc. (SGMD)
CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Sugarmade, Inc. (OTCQB: SGMD), a client of CNW investing in products and brands with disruptive potential. To view the full publication, titled “Cannabis Boom Fuels Mergers and Acquisitions in Hydroponics and Beyond,” visit: http://cnw.fm/5Kj62.
Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.
Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.
Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.
Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.
Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.
Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.
Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.
CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.
Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.
Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.
Sugarmade, Inc. (SGMD), closed the day's trading session at $0.097, off by 3.00%, on 1,024,801 volume with 143 trades. The average volume for the last 3 months is 2,282,585 and the stock's 52-week low/high is $0.0575/$0.43.
- CannabisNewsWire Announces Innovative Companies Expanding Amidst Rapidly-Growing Cannabis Sector
- NetworkNewsBreaks – Sugarmade, Inc. (SGMD) Investing in Products, Brands with Substantial Revenue Potential
- Cannabis Boom Fuels Mergers and Acquisitions in Hydroponics and Beyond
Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4)
Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) is pleased to announce that portfolio client Biolog Inc. has formed a partnership with Cannabis Strategic Ventures, Inc. (OTC:NUGS), to develop water-soluble cannabis technologies to be used as ingredients for cannabis and phytocannabinoid rich-infused foods, beverages and consumer products. Under the agreement, Biolog will develop the new technologies with Cannabis Strategic Ventures and will jointly deploy marketing efforts to get the products to the marketplace.
Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (FF: O3X4) is a merchant bank focused on providing debt and equity funding in the mid to late stages of a target company’s development and for technologies that are developed and validated by revenues. Redfund’s current focus is on medical cannabis, hemp and cannabidiol (CBD) related and healthcare-related companies.
As the first medical cannabis incubator and accelerator financing medical cannabis, CBD and hemp companies through a debt facility, Redfund is effectively bridging finance gaps and helping revenue-producing medical cannabis-related companies grow and build their valuations without prematurely diluting their equity.
The central components of the company’s business strategy are:
- Establishing the foundation of a loan portfolio that generates revenues through monthly interest income from loans to cover all general and administrative expenses related to day-to-day operations.
- Growing shareholder value by converting all or part of loans and warrants into equity in portfolio clients as clients build their valuations by entering the public markets or becoming the high-priced targets of larger entities.
Redfund was designed by bankers and entrepreneurs possessing years of experience in business, consulting, capital markets, corporate finance and healthcare services. The company is actively looking beyond borders and creating global companies that have strong fundamentals and are ready to expand.
Redfund’s investments are deployed to companies that have demonstrated success in their business but need a capital bridge in order to expand. Redfund’s team of professionals vet every project and analyzes each prospective client’s financials and business plans. Once a project is approved, Redfund’s legal team carefully scrutinizes the collateral used to securitize the individual loans.
The strategy employed by Redfund includes:
- Diversifying investments in Canada and other countries
- Building an international footprint with established national leaders
- Funding new drug delivery systems and helping nutraceuticals become mainstream drugs
- Introducing companies to Canada as a viable option for public listings
- Becoming a premier go-to lender for established companies
The company’s revenue sources include:
- Interest-bearing debt instruments with asset-backed collateral to securitize loans
- Equity kicker of warrants coverage on original loan
- Conversion ability of loan in its entirety
- Advisory fees from contracts for consulting on growth strategies
- Right of first refusal on future financing in each company funded
Redfund Capital Corp. (PNNRF), closed the day's trading session at $0.3042, off by 20.70%, on 5,675 volume with 9 trades. The average volume for the last 3 months is 368 and the stock's 52-week low/high is $2.2436/$0.505.
- Redfund Capital Client Biolog Inc. and Cannabis Strategic Ventures Inc. Announce Joint Development of Water-Soluble Cannabis Technology
- 420 with CNW – Cannabis PTSD Study Finally Secures Target Number of Participants
- Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4): A CBD Incubator & Accelerator with Global Reach
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- American Premium Water Corp. (HIPH) Political Change and E-commerce Drive Ongoing Growth for Cannabis Industry
- Aziza Project LLC, New Profile Released
- BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) to Present Updated Clinical Data Including Early Safety Data in KEYTRUDA® Combination Study and Positive Phase IIa Monotherapy Efficacy Data at 2018 San Antonio Breast Cancer Symposium
- Cannabis Strategic Ventures, Inc. (NUGS) Seeking Out Cultivation Facilities with Existing Infrastructure
- Canopy Rivers Inc. (TSXV: RIV) 420 with CNW – Cannabis PTSD Study Finally Secures Target Number of Participants
- Chemistree Technology Inc. (CSE: CHM) (OTC: CHMJF) Announces DTC Eligibility
- ChineseInvestors.com (CIIX) Creating New Revenue Opportunities in the Cannabis Industry
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) Expands into Medical Cannabis Channel with the Acquisition of Clarity Cannabis Medical Centres
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cyberfort Software, Inc. (CYBF) Stock Poised to Rise as Cyber Security Problems Proliferate
- CytoDyn Inc. (CYDY) to Present at Two Investment Conferences in December
- DPW Holdings, Inc. (NYSE American: DPW) Authorizes Pursuit of Spinoff of Super Crypto Mining, Inc. through a Special Dividend to Stockholders
- Earth Science Tech, Inc. (ETST) and Dermagate: A New Partnership in the Advancement of Women’s Health
- FinCanna Capital Corp. (CSE: CALI) (OTC: FNNZF) to Attend The Private Capital Markets Association of Canada Inaugural Western National Industry Conference
- First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF) Classifies Iron Creek Project as an Advanced, Unique Cobalt Asset
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) NetworkNewsBreaks – Foresight Autonomous Holdings to Present at 11th Annual LD Micro Main Event in Los Angeles
- Generation Alpha, Inc. (GNAL) to Present at LD Micro 11th Annual Main Event Investor Conference on December 5, 2018
- Global Payout, Inc. (GOHE) MTrac Signs Two of the Largest Cannabis Companies in the U.S and Paves the Way Into 3 New States
- Golden Developing Solutions, Inc. (DVLP) Page Views, App Downloads of ‘Where’s Weed’ Continue to Rise
- Green Hygienics Holdings Inc. (GRYN) Cannagram Services to Drive Vertical Expansion
- GreenBox POS, LLC (GRBX) POS Technology Selected for a Three Part Blockchain Business Series to Be Aired on Fox Business
- GTX Corp (GTXO) Provides Q3 2018 Financial Summary
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Mobile Hemp Oil Supplement Powder Packet, ChrgD+, Utilizes DehydraTECH Technology
- Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF) Provides Corporate Update and Announces Expansion to its Helados Prospect
- Marijuana Company of America Inc. (MCOA) CannabisNewsWire Announces Recent Washington, D.C., Changes Pave Way for Opportunity for Hemp and Cannabis Producers
- Medical Cannabis Payment Solutions (REFG) Offers First-Rate, End-to-End Payment Processing System to the Legal Cannabis Industry
- Net Element, Inc. (NASDAQ: NETE) 420 with CNW – Israeli Researchers Look into Treating Endometriosis Using Cannabis
- NUGL Inc. (NUGL) Scales Broad Launch Into the Cannabis Industry
- Pacific Software, Inc. (PFSF) Blockchain eCommerce Platform Enables Trade between Asian and Latin American Giants
- Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF) Uniquely Meeting Niche Market Needs
- Plus Products Inc. (CSE: PLUS) Top Edibles Brand in World's
- Pressure BioSciences Inc. (PBIO) CEO Featured in Interview with Christine Corrado of Proactive Investors
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Using Historic Exploration to its Advantage
- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) and Cannabis Strategic Ventures Inc. Announce Joint Development of Water-Soluble Cannabis Technology
- RYU Apparel Inc (TSX.V: RYU) (OTC: RYPPF) (FRA: RYA) announces "Respect" collaboration featuring designs from local artists
- Sharing Services, Inc. (SHRV) Stands Out from Many Small Companies through its Strong Financial Sales
- SinglePoint, Inc. (SING) Political Change and E-commerce Drive Ongoing Growth for Cannabis Industry
- Spectrum Global Solutions, Inc. (SGSI) Awarded Over $500,000 in New Contracts to Support Carrier Network Upgrades Across US
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Adds Seasoned Beverage Executive Michael Bellas to the Board of Directors
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Innovation and New Projects Direly Needed to Stem “Problematic” Lithium Supply Gap
- Sugarmade, Inc. (SGMD) CannabisNewsWire Announces Innovative Companies Expanding Amidst Rapidly-Growing Cannabis Sector
- Sunniva, Inc. (CSE: SNN) (OTC: SNNVF) Acquires LTYR Logistics, LLC
- Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) Grows Success through New Flowering Rooms, Expanding Distribution Network
- Teewinot Life Sciences Produces Cannabinoids through Patent-protected CANNSYNTHESIS Technology - QualityStocksNewsBreaks
- The Flowr Corp. (TSX.V: FLWR) Holds a Unique Advantage Over its Competitors
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) Expansion of CBD – Hemp Operations Continues to Explode as Demand and Sales Revenues Climb
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Details Plans for Cannabis Device-Focused Subsidiary - CannabisNewsBreaks
- TransCanna™ Set to Get Marijuana Moving Across California ‘Pot Desert’ Landscape
- United Battery Metals Corp. (CSE: UBM) (OTC: UBMCF) (FWB: 0UL) United Battery Metals Update
- Victory Marine Holdings Corp. (VMHG) Leveraging Experience to Expand its Reach
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) 420 with CNW – Marijuana Has No Effect on Kidney Transplant Outcomes, Research Finds
- Youngevity International, Inc. (NASDAQ: YGYI) Market Trends Toward New Normal - Emerging Consolidated Expectations, Analyst Ratings
- Zenergy Brands, Inc. (ZNGY) Makes the Virtual Utility a Reality
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.